| Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients CM Poh, G Carissimo, B Wang, SN Amrun, CYP Lee, RSL Chee, ... Nature communications 11 (1), 2806, 2020 | 382 | 2020 |
| Monkeypox: disease epidemiology, host immunity and clinical interventions FM Lum, A Torres-Ruesta, MZ Tay, RTP Lin, DC Lye, L Rénia, LFP Ng Nature Reviews Immunology 22 (10), 597-613, 2022 | 243 | 2022 |
| Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity SN Amrun, CYP Lee, B Lee, SW Fong, BE Young, RSL Chee, NKW Yeo, ... EBioMedicine 58, 2020 | 126 | 2020 |
| Asymptomatic COVID‐19: disease tolerance with efficient anti‐viral immunity against SARS‐CoV‐2 YH Chan, SW Fong, CM Poh, G Carissimo, NKW Yeo, SN Amrun, YS Goh, ... EMBO molecular medicine 13 (6), e14045, 2021 | 47 | 2021 |
| Factors associated with mental health in Peruvian medical students during the COVID-19 pandemic: a multicentre quantitative study J Huarcaya-Victoria, C Elera-Fitzcarrald, D Crisol-Deza, ... Revista Colombiana de Psiquiatría 52 (3), 236-244, 2023 | 42 | 2023 |
| Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose L Renia, YS Goh, A Rouers, N Le Bert, WN Chia, JM Chavatte, SW Fong, ... Nature Communications 13 (1), 4615, 2022 | 36 | 2022 |
| Decreased memory B cell frequencies in COVID‐19 delta variant vaccine breakthrough infection MZ Tay, A Rouers, SW Fong, YS Goh, YH Chan, ZW Chang, W Xu, ... EMBO molecular medicine 14 (3), e15227, 2022 | 34 | 2022 |
| Resistance of SARS-CoV-2 Delta variant to neutralization by BNT162b2-elicited antibodies in Asians B Wang, YS Goh, SW Fong, BE Young, EZX Ngoh, JM Chavatte, ... The Lancet Regional Health–Western Pacific 15, 2021 | 28 | 2021 |
| Viperin controls chikungunya virus–specific pathogenic T cell IFNγ Th1 stimulation in mice G Carissimo, TH Teo, YH Chan, CYP Lee, B Lee, A Torres-Ruesta, ... Life science alliance 2 (1), 2019 | 28 | 2019 |
| Robust virus-specific adaptive immunity in COVID-19 patients with SARS-CoV-2 Δ382 variant infection SW Fong, NKW Yeo, YH Chan, YS Goh, SN Amrun, N Ang, ... Journal of Clinical Immunology, 1-16, 2022 | 20 | 2022 |
| Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variant CYP Lee, SN Amrun, RSL Chee, YS Goh, TM Mak, S Octavia, NKW Yeo, ... Clinical & translational immunology 10 (2), e1241, 2021 | 16 | 2021 |
| Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients. Nat Commun 11: 2806 CM Poh, G Carissimo, B Wang, SN Amrun, CYP Lee, RSL Chee, ... | 12 | 2020 |
| Insights into antibody-mediated alphavirus immunity and vaccine development landscape A Torres-Ruesta, RSL Chee, LFP Ng Microorganisms 9 (5), 899, 2021 | 11 | 2021 |
| Data-driven analysis of COVID-19 reveals persistent immune abnormalities in convalescent severe individuals J Lim, KJ Puan, LW Wang, KWW Teng, CY Loh, KP Tan, G Carissimo, ... Frontiers in Immunology 12, 710217, 2021 | 10 | 2021 |
| Neutralizing antibodies from early cases of SARS-CoV-2 infection offer cross-protection against the SARS-CoV-2 D614G variant CYP Lee, SN Amrun, RSL Chee, YS Goh, TM Mak, S Octavia, NKW Yeo, ... bioRxiv, 2020.10. 08.332544, 2020 | 10 | 2020 |
| Pathogenic Th1 responses in CHIKV‐induced inflammation and their modulation upon Plasmodium parasites co‐infection A Torres‐Ruesta, TH Teo, YH Chan, L Rénia, LFP Ng Immunological Reviews 294 (1), 80-91, 2020 | 9 | 2020 |
| Type I interferon shapes the quantity and quality of the anti‐Zika virus antibody response CYP Lee, G Carissimo, Z Chen, FM Lum, F Abu Bakar, R Rajarethinam, ... Clinical & Translational Immunology 9 (4), e1126, 2020 | 9 | 2020 |
| Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity. EBioMedicine 58, 102911 SN Amrun, CYP Lee, B Lee, SW Fong, BE Young, RSL Chee, NKW Yeo, ... | 8 | 2020 |
| Malaria abrogates O’nyong–nyong virus pathologies by restricting virus infection in nonimmune cells A Torres-Ruesta, TH Teo, YH Chan, SN Amrun, NKW Yeo, CYP Lee, ... Life Science Alliance 5 (4), 2022 | 6 | 2022 |
| Longitudinal [18f] FB-IL-2 PET Imaging to Assess the Immunopathogenicity of O'nyong-Nyong Virus Infection YH Chan, TH Teo, A Torres-Ruesta, SV Hartimath, RSL Chee, ... Frontiers in Immunology 11, 894, 2020 | 6 | 2020 |
